Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease

Cell Metabolism

Volumn 22, Issue 1, 2015, Pages 125-137

  Börgeson, Emma ^a,b,c   Johnson, Andrew M F ^a   Lee, Yun Sok ^a   Till, Andreas ^d,e   Syed, Gulam Hussain ^a   Ali Shah, Syed Tasadaque ^f   Guiry, Patrick J ^f   Dalli, Jesmond ^g   Colas, Romain A ^g   Serhan, Charles N ^g   Sharma, Kumar ^a,b   Godson, Catherine ^c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e UNIVERSITY HOSPITAL BONN   (Germany)

^f UNIVERSITY COLLEGE DUBLIN   (Ireland)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; GLYCOPROTEIN P 15095; INTERLEUKIN 10; INTERLEUKIN 6; LIPOCORTIN 1; LIPOXIN; LIPOXIN A 4; PROTEIN P62; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; LIPOXIN A; NONSTEROID ANTIINFLAMMATORY AGENT;

ADIPOCYTE; ADIPOSE TISSUE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMINURIA; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; FATTY LIVER; FLOW CYTOMETRY; GENE EXPRESSION; IMMUNOFLUORESCENCE; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; LIVER WEIGHT; MACROPHAGE; NONHUMAN; OBESITY; PRIORITY JOURNAL; ANIMAL; AUTOPHAGY; C57BL MOUSE; COMPLICATION; DRUG EFFECTS; IMMUNOLOGY; KIDNEY; KIDNEY DISEASES; LIVER; LIVER DISEASES; PATHOLOGY;

MUS;

ADIPOSE TISSUE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AUTOPHAGY; INFLAMMATION; KIDNEY; KIDNEY DISEASES; LIPOXINS; LIVER; LIVER DISEASES; MICE, INBRED C57BL; OBESITY;

EID: 84937526093     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2015.05.003     Document Type: Article

References (61)

1. R.T. Akasheh, M. Pini, J. Pang, and G. Fantuzzi Increased adiposity in annexin A1-deficient mice PLoS ONE 8 2013 e82608
2. E. Börgeson, and C. Godson Resolution of inflammation: therapeutic potential of pro-resolving lipids in type 2 diabetes mellitus and associated renal complications Front. Immunol. 3 2012 318
3. E. Börgeson, and K. Sharma Obesity, immunomodulation and chronic kidney disease Curr. Opin. Pharmacol. 13 2013 618 624
4. E. Borgeson, N.G. Docherty, M. Murphy, K. Rodgers, A. Ryan, T.P. O'Sullivan, P.J. Guiry, R. Goldschmeding, D.F. Higgins, and C. Godson Lipoxin A(4) and benzo-lipoxin A(4) attenuate experimental renal fibrosis FASEB J. 25 2011 2967 2979
5. E. Borgeson, F.C. McGillicuddy, K.A. Harford, N. Corrigan, D.F. Higgins, P. Maderna, H.M. Roche, and C. Godson Lipoxin A4 attenuates adipose inflammation FASEB J. 26 2012 4287 4294
6. E.P. Brennan, K.A. Nolan, E. Börgeson, O.S. Gough, C.M. McEvoy, N.G. Docherty, D.F. Higgins, M. Murphy, D.M. Sadlier, S.T. Ali-Shah GENIE Consortium Lipoxins attenuate renal fibrosis by inducing let-7c and suppressing TGFβR1 J. Am. Soc. Nephrol. 24 2013 627 637
7. R. Cancello, J. Tordjman, C. Poitou, G. Guilhem, J.L. Bouillot, D. Hugol, C. Coussieu, A. Basdevant, A. Bar Hen, P. Bedossa, and et al. Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity Diabetes 55 2006 1554 1561
8. J. Clària, J. Dalli, S. Yacoubian, F. Gao, and C.N. Serhan Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat J. Immunol. 189 2012 2597 2605
9. J. Clària, B.T. Nguyen, A.L. Madenci, C.K. Ozaki, and C.N. Serhan Diversity of lipid mediators in human adipose tissue depots Am. J. Physiol. Cell Physiol. 304 2013 C1141 C1149
10. R.A. Colas, M. Shinohara, J. Dalli, N. Chiang, and C.N. Serhan Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue Am. J. Physiol. Cell Physiol. 307 2014 C39 C54
11. T.D. Cummins, C.R. Holden, B.E. Sansbury, A.A. Gibb, J. Shah, N. Zafar, Y. Tang, J. Hellmann, S.N. Rai, M. Spite, and et al. Metabolic remodeling of white adipose tissue in obesity Am. J. Physiol. Endocrinol. Metab. 307 2014 E262 E277
12. J. Dalli, and C.N. Serhan Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators Blood 120 2012 e60 e72
13. E. Demetz, A. Schroll, K. Auer, C. Heim, J.R. Patsch, P. Eller, M. Theurl, I. Theurl, M. Theurl, M. Seifert, and et al. The arachidonic acid metabolome serves as a conserved regulator of cholesterol metabolism Cell Metab. 20 2014 787 798
14. M.Y. Donath Targeting inflammation in the treatment of type 2 diabetes: time to start Nat. Rev. Drug Discov. 13 2014 465 476
15. M.Y. Donath, and S.E. Shoelson Type 2 diabetes as an inflammatory disease Nat. Rev. Immunol. 11 2011 98 107
16. M.Y. Donath, É. Dalmas, N.S. Sauter, and M. Böni-Schnetzler Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity Cell Metab. 17 2013 860 872
17. C. Finelli, and G. Tarantino What is the role of adiponectin in obesity related non-alcoholic fatty liver disease? World J. Gastroenterol. 19 2013 802 812
18. G. Fredman, L. Ozcan, S. Spolitu, J. Hellmann, M. Spite, J. Backs, and I. Tabas Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4 synthesis by inhibiting a calcium-activated kinase pathway Proc. Natl. Acad. Sci. USA 111 2014 14530 14535
19. A. González-Périz, and J. Clària Resolution of adipose tissue inflammation ScientificWorldJournal 10 2010 832 856
20. A. Gonzalez-Periz, R. Horrillo, N. Ferre, K. Gronert, B. Dong, E. Moran-Salvador, E. Titos, M. Martinez-Clemente, M. Lopez-Parra, V. Arroyo, and J. Claria Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins FASEB J. 23 2009 1946 1957
21. J. Hellmann, Y. Tang, M. Kosuri, A. Bhatnagar, and M. Spite Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice FASEB J. 25 2011 2399 2407
22. Y.H. Huang, H.M. Wang, Z.Y. Cai, F.Y. Xu, and X.Y. Zhou Lipoxin A4 inhibits NF-κB activation and cell cycle progression in RAW264.7 cells Inflammation 37 2014 1084 1090
23. J.H. Ix, and K. Sharma Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK J. Am. Soc. Nephrol. 21 2010 406 412
24. M. Kratz, B.R. Coats, K.B. Hisert, D. Hagman, V. Mutskov, E. Peris, K.Q. Schoenfelt, J.N. Kuzma, I. Larson, P.S. Billing, and et al. Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages Cell Metab. 20 2014 614 625
25. S. Krishnamoorthy, A. Recchiuti, N. Chiang, S. Yacoubian, C.H. Lee, R. Yang, N.A. Petasis, and C.N. Serhan Resolvin D1 binds human phagocytes with evidence for proresolving receptors Proc. Natl. Acad. Sci. USA 107 2010 1660 1665
26. I. Kure, S. Nishiumi, Y. Nishitani, T. Tanoue, T. Ishida, M. Mizuno, T. Fujita, H. Kutsumi, M. Arita, T. Azuma, and M. Yoshida Lipoxin A(4) reduces lipopolysaccharide-induced inflammation in macrophages and intestinal epithelial cells through inhibition of nuclear factor-kappaB activation J. Pharmacol. Exp. Ther. 332 2010 541 548
27. M.O. Leonard, K. Hannan, M.J. Burne, D.W. Lappin, P. Doran, P. Coleman, C. Stenson, C.T. Taylor, F. Daniels, C. Godson, and et al. 15-Epi-16-(para-fluorophenoxy)-lipoxin A(4)-methyl ester, a synthetic analogue of 15-epi-lipoxin A(4), is protective in experimental ischemic acute renal failure J. Am. Soc. Nephrol. 13 2002 1657 1662
28. B.D. Levy, Q.Y. Zhang, C. Bonnans, V. Primo, J.J. Reilly, D.L. Perkins, Y. Liang, M. Amin Arnaout, B. Nikolic, and C.N. Serhan The endogenous pro-resolving mediators lipoxin A4 and resolvin E1 preserve organ function in allograft rejection Prostaglandins Leukot. Essent. Fatty Acids 84 2011 43 50
29. Y. Li, L. Cai, H. Wang, P. Wu, W. Gu, Y. Chen, H. Hao, K. Tang, P. Yi, M. Liu, and et al. Pleiotropic regulation of macrophage polarization and tumorigenesis by formyl peptide receptor-2 Oncogene 30 2011 3887 3899
30. P. Li, Y. Oh, G. Bandyopadhyay, W.S. Lagakos, S. Talukdar, O. Osborn, A. Johnson, H. Chung, R. Mayoral, M. Maris, and et al. LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes Nat. Med. 21 2015 239 247
31. W. Liao, F. Zeng, K. Kang, Y. Qi, L. Yao, H. Yang, L. Ling, N. Wu, and D. Wu Lipoxin A4 attenuates acute rejection via shifting TH1/TH2 cytokine balance in rat liver transplantation Transplant. Proc. 45 2013 2451 2454
32. I. Locatelli, S. Sutti, A. Jindal, M. Vacchiano, C. Bozzola, C. Reutelingsperger, D. Kusters, S. Bena, M. Parola, C. Paternostro, and et al. Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice Hepatology 60 2014 531 544
33. C.N. Lumeng, J.L. Bodzin, and A.R. Saltiel Obesity induces a phenotypic switch in adipose tissue macrophage polarization J. Clin. Invest. 117 2007 175 184
34. P. Maderna, and C. Godson Lipoxins: resolutionary road Br. J. Pharmacol. 158 2009 947 959
35. J. Martinez, K. Verbist, R. Wang, and D.R. Green The relationship between metabolism and the autophagy machinery during the innate immune response Cell Metab. 17 2013 895 900
36. M. Masoodi, O. Kuda, M. Rossmeisl, P. Flachs, and J. Kopecky Lipid signaling in adipose tissue: Connecting inflammation & metabolism Biochim. Biophys. Acta 1851 2015 503 518
37. A.V. Mathew, S. Okada, and K. Sharma Obesity related kidney disease Curr. Diabetes Rev. 7 2011 41 49
38. J.C. McNelis, and J.M. Olefsky Macrophages, immunity, and metabolic disease Immunity 41 2014 36 48
39. A. Neuhofer, M. Zeyda, D. Mascher, B.K. Itariu, I. Murano, L. Leitner, E.E. Hochbrugger, P. Fraisl, S. Cinti, C.N. Serhan, and T.M. Stulnig Impaired local production of proresolving lipid mediators in obesity and 17-HDHA as a potential treatment for obesity-associated inflammation Diabetes 62 2013 1945 1956
40. T.P. O'Sullivan, K.S. Vallin, S.T. Shah, J. Fakhry, P. Maderna, M. Scannell, A.L. Sampaio, M. Perretti, C. Godson, and P.J. Guiry Aromatic lipoxin A4 and lipoxin B4 analogues display potent biological activities J. Med. Chem. 50 2007 5894 5902
41. D.Y. Oh, H. Morinaga, S. Talukdar, E.J. Bae, and J.M. Olefsky Increased macrophage migration into adipose tissue in obese mice Diabetes 61 2012 346 354
42. A. Ost, K. Svensson, I. Ruishalme, C. Brännmark, N. Franck, H. Krook, P. Sandström, P. Kjolhede, and P. Strålfors Attenuated mTOR signaling and enhanced autophagy in adipocytes from obese patients with type 2 diabetes Mol. Med. 16 2010 235 246
43. D. Patsouris, P.P. Li, D. Thapar, J. Chapman, J.M. Olefsky, and J.G. Neels Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals Cell Metab. 8 2008 301 309
44. M. Perretti, and F. D'Acquisto Annexin A1 and glucocorticoids as effectors of the resolution of inflammation Nat. Rev. Immunol. 9 2009 62 70
45. S.A. Polyzos, J. Kountouras, C. Zavos, and E. Tsiaousi The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease Diabetes Obes. Metab. 12 2010 365 383
46. P. Prieto, J. Cuenca, P.G. Través, M. Fernández-Velasco, P. Martín-Sanz, and L. Boscá Lipoxin A4 impairment of apoptotic signaling in macrophages: implication of the PI3K/Akt and the ERK/Nrf-2 defense pathways Cell Death Differ. 17 2010 1179 1188
47. Y. Qin, J.L. Hamilton, M.D. Bird, M.M. Chen, L. Ramirez, A. Zahs, E.J. Kovacs, and L. Makowski Adipose inflammation and macrophage infiltration after binge ethanol and burn injury Alcohol. Clin. Exp. Res. 38 2014 204 213
48. B. Rius, E. Titos, E. Moran-Salvador, C. Lopez-Vicario, V. Garcia-Alonso, A. Gonzalez-Periz, V. Arroyo, and J. Claria Resolvin D1 primes the resolution process initiated by calorie restriction in obesity-induced steatohepatitis FASEB J. 28 2014 836 848
49. A. Sasaki, H. Fukuda, N. Shiida, N. Tanaka, A. Furugen, J. Ogura, S. Shuto, N. Mano, and H. Yamaguchi Determination of ω-6 and ω-3 PUFA metabolites in human urine samples using UPLC/MS/MS Anal. Bioanal. Chem. 407 2015 1625 1639
50. C.N. Serhan Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways Annu. Rev. Immunol. 25 2007 101 137
51. C.N. Serhan, and J. Savill Resolution of inflammation: the beginning programs the end Nat. Immunol. 6 2005 1191 1197
52. K. Sharma The link between obesity and albuminuria: adiponectin and podocyte dysfunction Kidney Int. 76 2009 145 148
53. K. Sharma, S. Ramachandrarao, G. Qiu, H.K. Usui, Y. Zhu, S.R. Dunn, R. Ouedraogo, K. Hough, P. McCue, L. Chan, and et al. Adiponectin regulates albuminuria and podocyte function in mice J. Clin. Invest. 118 2008 1645 1656
54. M. Spite, J. Clària, and C.N. Serhan Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases Cell Metab. 19 2014 21 36
55. R. Stienstra, Y. Haim, Y. Riahi, M. Netea, A. Rudich, and G. Leibowitz Autophagy in adipose tissue and the beta cell: implications for obesity and diabetes Diabetologia 57 2014 1505 1516
56. Y.P. Sun, E. Tjonahen, R. Keledjian, M. Zhu, R. Yang, A. Recchiuti, P.S. Pillai, N.A. Petasis, and C.N. Serhan Anti-inflammatory and pro-resolving properties of benzo-lipoxin A(4) analogs Prostaglandins Leukot. Essent. Fatty Acids 81 2009 357 366
57. I. Tabas, and C.K. Glass Anti-inflammatory therapy in chronic disease: challenges and opportunities Science 339 2013 166 172
58. J. Tordjman, C. Poitou, D. Hugol, J.L. Bouillot, A. Basdevant, P. Bedossa, M. Guerre-Millo, and K. Clement Association between omental adipose tissue macrophages and liver histopathology in morbid obesity: influence of glycemic status J. Hepatol. 51 2009 354 362
59. D.P. Vasconcelos, M. Costa, I.F. Amaral, M.A. Barbosa, A.P. Águas, and J.N. Barbosa Modulation of the inflammatory response to chitosan through M2 macrophage polarization using pro-resolution mediators Biomaterials 37 2015 116 123
60. H. Wen, D. Gris, Y. Lei, S. Jha, L. Zhang, M.T. Huang, W.J. Brickey, and J.P. Ting Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling Nat. Immunol. 12 2011 408 415
61. T. Yoshizaki, C. Kusunoki, M. Kondo, M. Yasuda, S. Kume, K. Morino, O. Sekine, S. Ugi, T. Uzu, Y. Nishio, and et al. Autophagy regulates inflammation in adipocytes Biochem. Biophys. Res. Commun. 417 2012 352 357